BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 32649874)

  • 1. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
    Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
    Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression.
    Chen YJ; Roumeliotis TI; Chang YH; Chen CT; Han CL; Lin MH; Chen HW; Chang GC; Chang YL; Wu CT; Lin MW; Hsieh MS; Wang YT; Chen YR; Jonassen I; Ghavidel FZ; Lin ZS; Lin KT; Chen CW; Sheu PY; Hung CT; Huang KC; Yang HC; Lin PY; Yen TC; Lin YW; Wang JH; Raghav L; Lin CY; Chen YS; Wu PS; Lai CT; Weng SH; Su KY; Chang WH; Tsai PY; Robles AI; Rodriguez H; Hsiao YJ; Chang WH; Sung TY; Chen JS; Yu SL; Choudhary JS; Chen HY; Yang PC; Chen YJ
    Cell; 2020 Jul; 182(1):226-244.e17. PubMed ID: 32649875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
    Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
    Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteogenomic analysis of lung adenocarcinoma reveals tumor heterogeneity, survival determinants, and therapeutically relevant pathways.
    Soltis AR; Bateman NW; Liu J; Nguyen T; Franks TJ; Zhang X; Dalgard CL; Viollet C; Somiari S; Yan C; Zeman K; Skinner WJ; Lee JSH; Pollard HB; Turner C; Petricoin EF; Meerzaman D; Conrads TP; Hu H; ; Shriver CD; Moskaluk CA; Browning RF; Wilkerson MD
    Cell Rep Med; 2022 Nov; 3(11):100819. PubMed ID: 36384096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteogenomic characterization of pancreatic ductal adenocarcinoma.
    Cao L; Huang C; Cui Zhou D; Hu Y; Lih TM; Savage SR; Krug K; Clark DJ; Schnaubelt M; Chen L; da Veiga Leprevost F; Eguez RV; Yang W; Pan J; Wen B; Dou Y; Jiang W; Liao Y; Shi Z; Terekhanova NV; Cao S; Lu RJ; Li Y; Liu R; Zhu H; Ronning P; Wu Y; Wyczalkowski MA; Easwaran H; Danilova L; Mer AS; Yoo S; Wang JM; Liu W; Haibe-Kains B; Thiagarajan M; Jewell SD; Hostetter G; Newton CJ; Li QK; Roehrl MH; Fenyö D; Wang P; Nesvizhskii AI; Mani DR; Omenn GS; Boja ES; Mesri M; Robles AI; Rodriguez H; Bathe OF; Chan DW; Hruban RH; Ding L; Zhang B; Zhang H;
    Cell; 2021 Sep; 184(19):5031-5052.e26. PubMed ID: 34534465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteogenomic portrait of lung squamous cell carcinoma.
    Satpathy S; Krug K; Jean Beltran PM; Savage SR; Petralia F; Kumar-Sinha C; Dou Y; Reva B; Kane MH; Avanessian SC; Vasaikar SV; Krek A; Lei JT; Jaehnig EJ; Omelchenko T; Geffen Y; Bergstrom EJ; Stathias V; Christianson KE; Heiman DI; Cieslik MP; Cao S; Song X; Ji J; Liu W; Li K; Wen B; Li Y; Gümüş ZH; Selvan ME; Soundararajan R; Visal TH; Raso MG; Parra ER; Babur Ö; Vats P; Anand S; Schraink T; Cornwell M; Rodrigues FM; Zhu H; Mo CK; Zhang Y; da Veiga Leprevost F; Huang C; Chinnaiyan AM; Wyczalkowski MA; Omenn GS; Newton CJ; Schurer S; Ruggles KV; Fenyö D; Jewell SD; Thiagarajan M; Mesri M; Rodriguez H; Mani SA; Udeshi ND; Getz G; Suh J; Li QK; Hostetter G; Paik PK; Dhanasekaran SM; Govindan R; Ding L; Robles AI; Clauser KR; Nesvizhskii AI; Wang P; Carr SA; Zhang B; Mani DR; Gillette MA;
    Cell; 2021 Aug; 184(16):4348-4371.e40. PubMed ID: 34358469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma.
    Tong Y; Sun M; Chen L; Wang Y; Li Y; Li L; Zhang X; Cai Y; Qie J; Pang Y; Xu Z; Zhao J; Zhang X; Liu Y; Tian S; Qin Z; Feng J; Zhang F; Zhu J; Xu Y; Lou W; Ji Y; Zhao J; He F; Hou Y; Ding C
    J Hematol Oncol; 2022 Nov; 15(1):168. PubMed ID: 36434634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative Proteomic Characterization of Human Lung Adenocarcinoma.
    Xu JY; Zhang C; Wang X; Zhai L; Ma Y; Mao Y; Qian K; Sun C; Liu Z; Jiang S; Wang M; Feng L; Zhao L; Liu P; Wang B; Zhao X; Xie H; Yang X; Zhao L; Chang Y; Jia J; Wang X; Zhang Y; Wang Y; Yang Y; Wu Z; Yang L; Liu B; Zhao T; Ren S; Sun A; Zhao Y; Ying W; Wang F; Wang G; Zhang Y; Cheng S; Qin J; Qian X; Wang Y; Li J; He F; Xiao T; Tan M
    Cell; 2020 Jul; 182(1):245-261.e17. PubMed ID: 32649877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
    Zhang Y; Fu F; Zhang Q; Li L; Liu H; Deng C; Xue Q; Zhao Y; Sun W; Han H; Gao Z; Guo C; Zheng Q; Hu H; Sun Y; Li Y; Ding C; Chen H
    Cell Rep Med; 2024 Jan; 5(1):101358. PubMed ID: 38183982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
    Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
    Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
    [No Abstract]   [Full Text] [Related]  

  • 14. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
    Petralia F; Tignor N; Reva B; Koptyra M; Chowdhury S; Rykunov D; Krek A; Ma W; Zhu Y; Ji J; Calinawan A; Whiteaker JR; Colaprico A; Stathias V; Omelchenko T; Song X; Raman P; Guo Y; Brown MA; Ivey RG; Szpyt J; Guha Thakurta S; Gritsenko MA; Weitz KK; Lopez G; Kalayci S; Gümüş ZH; Yoo S; da Veiga Leprevost F; Chang HY; Krug K; Katsnelson L; Wang Y; Kennedy JJ; Voytovich UJ; Zhao L; Gaonkar KS; Ennis BM; Zhang B; Baubet V; Tauhid L; Lilly JV; Mason JL; Farrow B; Young N; Leary S; Moon J; Petyuk VA; Nazarian J; Adappa ND; Palmer JN; Lober RM; Rivero-Hinojosa S; Wang LB; Wang JM; Broberg M; Chu RK; Moore RJ; Monroe ME; Zhao R; Smith RD; Zhu J; Robles AI; Mesri M; Boja E; Hiltke T; Rodriguez H; Zhang B; Schadt EE; Mani DR; Ding L; Iavarone A; Wiznerowicz M; Schürer S; Chen XS; Heath AP; Rokita JL; Nesvizhskii AI; Fenyö D; Rodland KD; Liu T; Gygi SP; Paulovich AG; Resnick AC; Storm PB; Rood BR; Wang P; ;
    Cell; 2020 Dec; 183(7):1962-1985.e31. PubMed ID: 33242424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteogenomic landscape of squamous cell lung cancer.
    Stewart PA; Welsh EA; Slebos RJC; Fang B; Izumi V; Chambers M; Zhang G; Cen L; Pettersson F; Zhang Y; Chen Z; Cheng CH; Thapa R; Thompson Z; Fellows KM; Francis JM; Saller JJ; Mesa T; Zhang C; Yoder S; DeNicola GM; Beg AA; Boyle TA; Teer JK; Ann Chen Y; Koomen JM; Eschrich SA; Haura EB
    Nat Commun; 2019 Aug; 10(1):3578. PubMed ID: 31395880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
    Krug K; Jaehnig EJ; Satpathy S; Blumenberg L; Karpova A; Anurag M; Miles G; Mertins P; Geffen Y; Tang LC; Heiman DI; Cao S; Maruvka YE; Lei JT; Huang C; Kothadia RB; Colaprico A; Birger C; Wang J; Dou Y; Wen B; Shi Z; Liao Y; Wiznerowicz M; Wyczalkowski MA; Chen XS; Kennedy JJ; Paulovich AG; Thiagarajan M; Kinsinger CR; Hiltke T; Boja ES; Mesri M; Robles AI; Rodriguez H; Westbrook TF; Ding L; Getz G; Clauser KR; Fenyö D; Ruggles KV; Zhang B; Mani DR; Carr SA; Ellis MJ; Gillette MA;
    Cell; 2020 Nov; 183(5):1436-1456.e31. PubMed ID: 33212010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Effects of Different Levels of Genomic Data for the Staging of Lung Adenocarcinoma: An Illustrative Study.
    Li Y; Mansmann U; Du S; Hornung R
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Across the Globe: Proteogenomic Landscapes of Lung Cancer.
    Yanovich-Arad G; Geiger T
    Cell; 2020 Jul; 182(1):9-11. PubMed ID: 32649881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis reveals distinct subtypes with therapeutic implications in KRAS-mutant lung adenocarcinoma.
    Liu K; Guo J; Liu K; Fan P; Zeng Y; Xu C; Zhong J; Li Q; Zhou Y
    EBioMedicine; 2018 Oct; 36():196-208. PubMed ID: 30268834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).
    Aisner DL; Sholl LM; Berry LD; Rossi MR; Chen H; Fujimoto J; Moreira AL; Ramalingam SS; Villaruz LC; Otterson GA; Haura E; Politi K; Glisson B; Cetnar J; Garon EB; Schiller J; Waqar SN; Sequist LV; Brahmer J; Shyr Y; Kugler K; Wistuba II; Johnson BE; Minna JD; Kris MG; Bunn PA; Kwiatkowski DJ;
    Clin Cancer Res; 2018 Mar; 24(5):1038-1047. PubMed ID: 29217530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.